Home › U.S. regulators reject Sanofi's MS treatment Lemtrada
 

Keywords :   


U.S. regulators reject Sanofi's MS treatment Lemtrada

2014-01-01 22:27:11| Biotech - Topix.net

Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.

Tags: treatment reject regulators sanofis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »